Most employers have little idea what the pharmacy benefit managers they hire do with the money they exchange for the medications used by their employees, according to a KFF survey released Wednesday ...

As healthcare costs continue to rise, businesses face increasing pressure to balance comprehensive benefits with financial sustainability. One of the most significant challenges is the escalating cost ...

Diabetes and obesity drugs also lead to large reductions in adverse cardiovascular events, and the benefits aren’t just down ...

GLP-1s are building a reputation as "wonder drugs." First characterized for their ability to improve insulin release and ...

Researchers suggest that a simple explanation of the benefits and harms of a medication could improve a patient’s drug of choice, according to a Dartmouth College release. Previous research suggests ...

When approved drugs do not exist for a species, condition or delivery route, compounded medications can fill the gap. These formulations provide new flexibility for managing livestock health.

Medicare Advantage insurers leaving certain markets affected more than 1 in 10 Americans enrolled in such plans with prescription drug coverage, a KFF analysis shows.

The rise of GLP-1 medications, including Ozempic and Wegovy, has garnered significant attention in recent years, particularly among those seeking weight loss and enhanced health. Originally developed ...

If you’ve ever tried to lose weight and wondered why diet and exercise aren’t cutting it, you’re not alone. Millions of people struggle with weight loss despite their best efforts, and it’s not always ...

As ADHD medication use has surged in Sweden over the past decades, evidence is needed on whether the benefit of the medication remains consistent. A new study from Karolinska Institutet, published in ...